In these models melanoma-relevant genetic changes such as Pten loss and Braf activation drive transformation of normal mouse melanocytes into melanoma leaving surrounding tissue unaltered, thus recapitulating complex host-tumor interactions that occur through tumor development. This evidence concerns the gene BRAF and melanoma.